SCHEMBL4626504

SCHEMBL4626504

CC(N)(Cc1ccc2nc(-c3c(Cl)cccc3Cl)ccc2c1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 3/20 0.53
ITGAV P06756 1/20 0.53
CYP1A2 P05177 3/20 0.46
MAPT P10636 3/20 0.46
BLM P54132 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
EGFR P00533 2/20 0.46
KDM4E B2RXH2 1/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.46
FYN P06241 1/20 0.46
POLB P06746 1/20 0.46
CYP3A4 P08684 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
APEX1 P27695 1/20 0.46
ADRA1A P35348 1/20 0.46
PTGS2 P35354 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4750015 1.00 ITGB1 (0.53) ITGB1ITGAVCYP1A2MAPTBLM
SCHEMBL4625484 0.83 KDM4E (0.50) ITGB1ITGAVCYP1A2MAPTBLM
SCHEMBL3319930 0.81 ITGB1 (0.61) ITGB1ITGAVCYP1A2MAPTKMT2A
SCHEMBL4625490 0.79 ITGB1 (0.59) ITGB1ITGAVKMT2AALDH1A1HPGD
SCHEMBL1030228 0.79 ITGB1 (0.49) ITGB1ITGAVCYP1A2MAPTKDM4E
SCHEMBL1028112 0.78 ITGB1 (0.55) ITGB1ITGAVCYP1A2MAPTKMT2A
SCHEMBL3317946 0.77 ITGB1 (0.58) ITGB1ITGAVCYP1A2ABL1FFAR1
SCHEMBL4747267 0.77 ITGB1 (0.47) ITGB1ITGAVABL1
SCHEMBL3314275 0.77 ITGB1 (0.67) ITGB1ITGAVCYP1A2MAPTMEN1
SCHEMBL3318103 0.77 ITGB1 (0.67) ITGB1ITGAVCYP1A2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 EP disclosed